Director David B. Wells of Hims & Hers Health, Inc. filed a statement of changes in beneficial ownership on November 17, 2026, reporting a restricted stock unit conversion on November 13, 2026.
Key Highlights
- Reporting person: David B. Wells, identified as a Director of Hims & Hers Health, Inc. (NYSE:HIMS).
- Transaction: 1,051 restricted stock units (RSUs) converted to Class A Common Stock on November 13, 2026, via transaction code M.
- RSU grant price: $28.53 per share, used to calculate the number of RSUs issued in lieu of a $30,000 cash director retainer fee for Q3 2026.
- Resulting ownership: Wells directly held 230,859 shares of Class A Common Stock following the transaction, according to the filing.
- Vesting schedule: The RSUs were stated to vest in full on the company's next quarterly vesting date.
- Derivative position: Following the conversion, Wells held zero RSUs of this grant in Table II, the filing disclosed.
Wells Receives Director Retainer in Hims & Hers Equity, Not Cash
According to the filing, David B. Wells received 1,051 RSUs from Hims & Hers Health, Inc. under the company's Director Compensation Policy. The RSUs were issued in lieu of the director retainer fee for the third quarter of 2026, with the number of units calculated by dividing foregone cash fees of $30,000 by a grant price of $28.53 per share. Each RSU represented a contingent right to receive one share of Class A Common Stock.
The transaction code reported was M, indicating a conversion of derivative securities into the underlying Class A Common Stock. Following the conversion, the filing recorded Wells's direct beneficial ownership at 230,859 shares of Class A Common Stock. The RSU derivative position reported in Table II shows zero units remaining under this grant after the November 13, 2026 transaction date, consistent with a full conversion of the 1,051 units.
Hims & Hers Health, Inc. operates as a consumer health company, and its Class A Common Stock is listed on the New York Stock Exchange under the ticker HIMS. The filing was signed by Kimberly Mather as Attorney-in-Fact for David B. Wells and dated November 17, 2026.
What Was Disclosed
The filing reported that director David B. Wells converted 1,051 RSUs into an equal number of Class A Common Stock shares on November 13, 2026, under the Hims & Hers Health Director Compensation Policy, bringing his directly held share count to 230,859.




Please wait processing your request...